سعر اوبلكس-ان شراب 125 مل 2024

Guaifenesin + Oxomemazine + Sodium benzoate syrup, an antitussive/expectorant combination, Egyptian product (Amriya Pharmaceutical Industries).

• Oxomemazine: hypersensitivity to antihistamines; infants under 2 years; history of agranulocytosis; risk of urinary retention due to urethro-prostatic disorders; risk of angle-closure glaucoma; combination with cabergoline or quinagolide.General active-ingredient information · ANSM - Base de données publique des médicaments

• Productive cough should be respected; the French SmPC considers combining an expectorant or mucolytic with this antitussive illogical. Look for causes of cough needing specific treatment; do not increase doses if cough persists. Reinforced monitoring in epilepsy (lowered seizure threshold).General active-ingredient information · ANSM - Base de données publique des médicaments

• Oxomemazine is not recommended during breastfeeding (possible neonatal sedation or paradoxical excitation and phenothiazine-associated sleep apnoea risk).General active-ingredient information · ANSM - Base de données publique des médicaments

English text not available for this section.